Table 3.
Wild type K13 with postulated Artemisinin (ART) resistance.
Location | Isolates | Assessment criteria | Reference |
---|---|---|---|
Odisha, India | 3 | DPC3 +ve | Bharti et al. (2016) |
Uganda | 3 | Ex-vivo RSA >10% | (Ikeda et al., 2018) |
Asia wide study | 21 | PCHL > 5 h | Ashley et al. (2014) |
China-Myanmar border | 1 | Ex-vivo RSA >14% | Ye et al. (2016) |
Cambodia | 4 | In-vitro RSA > 0.8% | Mukherjee et al. (2017) |